Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Some Phase 3 trial sites are in Asia (REDEFINE 5, REDEFINE 6) but no regulatory approvals have been announced as of June 2026
[PMID: 33051481] PubMed record related to this compound for laboratory literature review
Observed effects in experimental models include: Transient fatigue or lethargy following administration in animal models
Additionally, there was a notable decrease in associated depressive states [10]
Factors that increase side effect risk While AOD 9604 has a favorable safety profile, certain factors can increase the likelihood or severity of unwanted effects
If you have any additional questions, please do not hesitate to reach out to our clinic
US$ 24.45
US$ 21.81
US$ 24.61
US$ 23.92
